Abveris is a contract lab discovering monoclonal antibodies for reagent and therapeutic purposes. Using proprietary engineered in vivo systems, Abveris delivers hybridomas producing murine mABs to targets that cannot be found in natural in vivo systems.
Rapid Delivery Timelines
Delivery of custom-screened monoclonal hybridoma cell lines producing IgG monoclonal antibodies in tight timelines.
Science as a Service
The service component is important to us.
We provide a better antibody discovery service for the increasingly competitive biologics market.
An optimized in vivo platform
mAbs targeting non-immunogenic epitopes
The limiting factor in most in vivo antibody discovery platforms is the diversity of the immune response of the host animal. Abveris uses a proprietary rodent that has been engineered to express a more diverse antibody repertoire than regular animals. This enables the discovery of antibodies with specificities that cannot be found in other in vivo systems.
Natual Immune Reaction
DiversimAb Immune Reaction
OUR SERVICES
Anti-idiotypic mAbs
Our specialty! We screen for ideal PK/ADA reagents targeting IgG’s and funky molecules alike. Rapid delivery available.
Learn More
Therapeutic Antibody Discovery
Rapid discovery of diverse panels of mAbs custom screened to your specifications.
Learn More
Cell surface targeting mAbs
DNA immunization, flow cytometry screening and other options are available.
Learn More
Reagent discovery
Panels of custom-screened mAbs delivered to your specifications. Difficult targets are welcome.
Learn More